Shanghai Allist Pharmaceuticals Co., Ltd. (SHA: 688578)
China flag China · Delayed Price · Currency is CNY
56.37
+5.85 (11.58%)
Nov 20, 2024, 3:00 PM CST

Shanghai Allist Pharmaceuticals Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Operating Revenue
3,2042,018790.94530.080.550.63
Upgrade
Other Revenue
0.060.060.060.020.02-
Upgrade
Revenue
3,2042,018791530.090.560.63
Upgrade
Revenue Growth (YoY)
97.64%155.14%49.22%94409.97%-10.93%-86.37%
Upgrade
Cost of Revenue
164.74110.0247.1129.950.160.27
Upgrade
Gross Profit
3,0391,908743.9500.140.40.36
Upgrade
Selling, General & Admin
1,4211,052524.11366.44185.12234.71
Upgrade
Research & Development
297.24280.92175.71200.61175.42159.5
Upgrade
Other Operating Expenses
49.6426.65.112.791.641.82
Upgrade
Operating Expenses
1,7661,359705.26569.95362.16396.04
Upgrade
Operating Income
1,273549.5638.64-69.81-361.76-395.68
Upgrade
Interest Expense
-0.13-0.16-0.33-0.61-1.14-7.76
Upgrade
Interest & Investment Income
76.260.1933.0630.0621.416.46
Upgrade
Currency Exchange Gain (Loss)
4.354.3517.17-3.38-0.35-1.09
Upgrade
Other Non Operating Income (Expenses)
-10.08-0.26-1.06-0.43-0.1-0.12
Upgrade
EBT Excluding Unusual Items
1,343613.6887.47-44.16-341.96-388.2
Upgrade
Gain (Loss) on Sale of Investments
18.6622.6732.3648.138.34.4
Upgrade
Gain (Loss) on Sale of Assets
-0.02-0.02-1.68-0.57--0.03
Upgrade
Asset Writedown
-----0.02-
Upgrade
Other Unusual Items
58.9719.897.8514.8823.16-13.68
Upgrade
Pretax Income
1,421656.2212618.27-310.52-397.5
Upgrade
Income Tax Expense
124.0512.05-4.52---
Upgrade
Net Income
1,297644.17130.5218.27-310.52-397.5
Upgrade
Net Income to Common
1,297644.17130.5218.27-310.52-397.5
Upgrade
Net Income Growth
166.25%393.54%614.22%---
Upgrade
Shares Outstanding (Basic)
450450450457370361
Upgrade
Shares Outstanding (Diluted)
450450450457370361
Upgrade
Shares Change (YoY)
-0.28%0.09%-1.49%23.59%2.30%-
Upgrade
EPS (Basic)
2.881.430.290.04-0.84-1.10
Upgrade
EPS (Diluted)
2.881.430.290.04-0.84-1.10
Upgrade
EPS Growth
166.99%393.10%625.00%---
Upgrade
Free Cash Flow
1,219606.77-52.21-162.95-285.2-348.74
Upgrade
Free Cash Flow Per Share
2.711.35-0.12-0.36-0.77-0.97
Upgrade
Dividend Per Share
0.6500.400----
Upgrade
Gross Margin
94.86%94.55%94.04%94.35%71.17%57.06%
Upgrade
Operating Margin
39.73%27.23%4.88%-13.17%-64498.21%-62833.77%
Upgrade
Profit Margin
40.47%31.92%16.50%3.45%-55361.45%-63123.39%
Upgrade
Free Cash Flow Margin
38.05%30.07%-6.60%-30.74%-50847.96%-55379.94%
Upgrade
EBITDA
1,322586.558.8-56-349.9-386.14
Upgrade
EBITDA Margin
41.27%29.06%7.43%-10.56%--
Upgrade
D&A For EBITDA
49.5336.9420.1613.8111.869.54
Upgrade
EBIT
1,273549.5638.64-69.81-361.76-395.68
Upgrade
EBIT Margin
39.73%27.23%4.88%-13.17%--
Upgrade
Effective Tax Rate
8.73%1.84%----
Upgrade
Revenue as Reported
3,2042,018791530.090.560.63
Upgrade
Advertising Expenses
-552.06201.3822.440.47-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.